The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ARTO trial: Overall survival analysis from a randomized phase II trial testing the benefit of adding stereotactic body radiotherapy to abiraterone acetate in patients with oligometastatic castrate-resistant prostate cancer.
 
Giulio Francolini
No Relationships to Disclose
 
Vanessa Di Cataldo
No Relationships to Disclose
 
Pietro Garlatti
No Relationships to Disclose
 
Beatrice Detti
No Relationships to Disclose
 
Saverio Caini
No Relationships to Disclose
 
Alessio Bruni
No Relationships to Disclose
 
Gianluca Ingrosso
Honoraria - Bayer; Ipsen; Takeda
Travel, Accommodations, Expenses - Ipsen
 
Rolando Maria D'Angelillo
No Relationships to Disclose
 
Anna Rita Alitto
Consulting or Advisory Role - Janssen Oncology
 
Matteo Augugliaro
Travel, Accommodations, Expenses - Ipsen
 
Luca Triggiani
No Relationships to Disclose
 
Silvana Parisi
No Relationships to Disclose
 
Gaetano Facchini
No Relationships to Disclose
 
Marco Banini
No Relationships to Disclose
 
Gabriele Simontacchi
No Relationships to Disclose
 
Isacco Desideri
No Relationships to Disclose
 
Icro Meattini
Honoraria - Accuray; Lilly; Novartis; Pfizer; Seagen
 
Richard K. Valicenti
No Relationships to Disclose
 
Lorenzo Livi
No Relationships to Disclose